Across TCGA pan-cancer cohorts, RNA5SP324 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNA5SP324’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNA5SP324 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNA5SP324 is over-expressed in tumor.
KIRC and UCEC are the cancer types where RNA5SP324 tumor–normal differential expression is most reproducible.